Postual Control in Pediatric Chiari I Malformation

NCT ID: NCT04679792

Last Updated: 2020-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-01

Study Completion Date

2022-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

BACKGROUND: Chiari I malformation is a rare disease characterized by cerebellar amygdalae descent under the level of the foramen magnum. It causes troubles in cerebrospinal fluid circulation and direct compression on brainstem, producing characteristic headaches, neurological impairment and syringomyelia. Surgery is the only treatment, indicated when symptomatology exists. However, sometimes patients complaint about atypical symptoms that are difficult to interpret.

We would like to study one of these atypical symptoms, gait imbalance, in a pediatric population thanks to a computerized dynamic posturography (Equitest®).

METHOD: infants from 6 to 18 years of age presenting a radiologically confirmed Chiari I malformation will be included in the study. We will compare posturographic results of patients which will be operated on with the results of the patients which will not; furthermore, we will compare preoperative and postoperative results in operated patients.

RESULTS: 19 patients have been enrolled in the study, and data have been collected for 12 of them. Seven patients belong to operated population.

CONCLUSIONS: even if enrolment of the patients is satisfactory, disposable data are not enough to perform statistical analysis and to put forward any conclusion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chiari malformation is characterized by at least 5 mm descent of cerebellar tonsils below the foramen magnum, into the vertebral canal. Historical classification of this malformation consists in four different types, but it is the first one, due to a congenital small posterior fossa, which represent our focus of interest. Chiari malformation may leads to direct brainstem compression and to cerebrospinal fluid circulation trouble at this level, being cause of classical associated phenomena such as syringomyelia formation.

The clinical manifestation may be resumed as follow:

* Exertional headaches or neck pain.
* Brainstem compression signs and symptoms (central apneas syndrome, tetraparesis, paresthesia, cranial nerves disfunction...).
* Syringomyelia signes and symptoms (neuropathic pain, suspended hypo-anesthesia).

The only treatment for Chiari I malformation is the surgical one. It consists in an osteo-dural decompression of the posterior fossa. Surgical decision is formal when at least one of the following criteria is satisfied:

* presence of syringomyelia;
* coexistence of central apneas syndrome;
* presence of the classical symptomatology. Nevertheless, the spectrum of symptoms which might be reported by the patient, and which has even been described in the non neurosurgical literature, is largely wider than the previously thought and assumed by the neurosurgeons. There are so several "atypical symptoms" in which neurosurgeons doesn't believed, and that don't constitute an indicator for surgical intervention. Among these "atypical symptoms" one cas find those ones who bring back to ear, nose and throat domain, such as nystagmus, dizziness, tinnitus, hear loss, and gait instability.

We decided to focalise about one of these symptoms, the gait instability, trying to find the link between Chiari malformation and postural control. In the literature, there are only one study concerning this aspect, conducted on an adult population with the help of a static posturography.

Our study will focus on pediatric patients, who will be evaluated by a dynamic posturography, the Equitest platform (NeuroCom, Clackamas, OR). This platform is able to quantify the contribution of each of the three sensory informations (visual, vestibular and somatosensory) necessary to maintain equilibrium, realising a specific test (Sensory Organisation Test).

The Equitest can elaborate a Composite Equilibrium Score (CES), that will be our PRIMARY JUDGMENT CRITERIA.

Only patients for which ENT evaluation is indicated for medical reasons (for example, children presented frequent falls, dizziness, nystagmus, motion sickness...) will be evaluated.

This evaluation won't change habitual neurosurgical care for the patients presenting Chiari I malformation, so two groups of patients will be identified: children who will be operated on and children who won't. CES of the two groups will be calculated and compared.

Furthermore, we will compared CES results of the operated patients group before and after surgery, to evaluate the impact of surgery on postural control.

In parallel, we will evaluate others SECONDARY CRITERIA in operated patient, before and after surgery, such as :

* signe and symptomss modification;
* decompression result on MRI images;
* syringomyelia modification, if present before;
* central apnea syndrome modification, if present before;
* scoliosis modification, if present before;
* behavioral modification. Anamnestic and clinical data will be part of the habitual computerized medical folder, as well as polysomnographic, posturographic and imaging ones.

Clinical elements of recruited patients will be collected by principal investigator in an anonymous database, secured by a password.

Concerning primary criteria, collected qualitative data will be analysed by Chi-2 or Fischer test, while quantitative ones will be analysed by Student's test or Mann-Whitney one.

Concerning secondary criteria, collected qualitative data will be analysed by Mc Nemar test or symmetry test, while quantitative ones will be analysed by Student's test Wilcoxon one.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chiari I Malformation Pediatric

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

operated

Patients Under 18 years of age who are operated for Chiari Malformation on the basis of routine neurosurgical assessment.

Dynamic posturography

Intervention Type DIAGNOSTIC_TEST

Balance evaluation

non operated

Patients Under 18 years of age who are not operated for Chiari Malformation on the basis of routine neurosurgical assessment.

Dynamic posturography

Intervention Type DIAGNOSTIC_TEST

Balance evaluation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dynamic posturography

Balance evaluation

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Radiologically confirmed diagnosis of Chiari I malformation (first MRI realized up to 1/01/2018)
* ENT symptomes (dizziness, nystagmus, gait imbalance, migraines not due to the presence of Chiari Malformation)

Exclusion Criteria

* Lack of cooperation (cerebral palsy, severe behavioral troubles, orthopedic illness, severe visual impairment)
* Patient's consent for study non obtained.
Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lorraine

OTHER

Sponsor Role collaborator

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Philippe PERRIN

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Perrin Philippe, PhD

Role: STUDY_DIRECTOR

Nancy Regional University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stella Irene

Vandœuvre-lès-Nancy, Lorraine, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stella Irene, MD

Role: CONTACT

Phone: +33383155207

Email: [email protected]

Klein Olivier, PhD

Role: CONTACT

Phone: +33383155208

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stella Irene, MD

Role: primary

KLEIN Olivier

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Stella I, Remen T, Petel A, Joud A, Klein O, Perrin P. Postural control in Chiari I malformation: protocol for a paediatric prospective, observational cohort - potential role of posturography for surgical indication. BMJ Open. 2022 May 12;12(5):e056647. doi: 10.1136/bmjopen-2021-056647.

Reference Type DERIVED
PMID: 35551083 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EquiChiari

Identifier Type: -

Identifier Source: org_study_id